Possible participation of pICln in the regulation of angiogenesis through alternative splicing of vascular endothelial growth factor receptor mRNAs

Endothelium. 2004 Sep-Dec;11(5-6):293-300. doi: 10.1080/10623320490904250.

Abstract

In this study, the authors applied a modified Antisense Display method to human vascular endothelial cells (ECs) in culture to isolate new angiostatic genes. Screening of a 10mer antisense oligodeoxyribonucleotide (oligo) repertoire identified a subpool that consistently stimulated EC growth. Subsequent screening of oligos with increasing chain length led to the isolation of a unique growth-stimulatory 14mer, 5'-TTCCACATCATATT-3'. cDNA/EST data-base search and expression analyses in ECs indicated pICln as the corresponding gene. A longer unique antisense oligo against a different region of pICln mRNA was found to also enhance EC growth and tube formation and to decrease mRNAs for soluble Flt-1 and neuropilin-1 vascular endothelial growth factor (VEGF) receptors, the angiostatic factors that are generated by alternative RNA splicing. Conversely,pICln overexpression suppressed EC growth and increased the mRNAs for both soluble Flt-1 and soluble neuropilin-1. The present findings thus suggest that pICln plays a role in autocrine regulation of angiogenesis, probably through alternative splicing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Antisense Elements (Genetics)
  • Humans
  • Neovascularization, Physiologic / physiology
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / genetics*
  • RNA, Messenger / metabolism*
  • Receptors, Vascular Endothelial Growth Factor / biosynthesis
  • Receptors, Vascular Endothelial Growth Factor / genetics*

Substances

  • Antisense Elements (Genetics)
  • Protein Isoforms
  • RNA, Messenger
  • Receptors, Vascular Endothelial Growth Factor